NIH PAR · NIGMS · R01
PAR-25-203: Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
This Notice of Funding Opportunity (NOFO) supports projects relevant to the NIGMS mission that focus solely on the development of technologies with potential to enable acquisition of biomedical knowledge. Projects should be justified in terms of technical innovation and utility of such technical innovation for impacting future biomedical research. Outcomes or products of the proposed project should significantly advance the current state of the art and be sufficiently characterized for application in addressing a broad range of biomedical research questions.
- NOFO number
- PAR-25-203
- Type
- PAR
- Activity code
- R01
- Primary institute
- NIGMS · National Institute of General Medical Sciences
- Clinical trials
- Not Allowed
- Posted
- Nov 14, 2024
- Opens
- Jan 5, 2025
- Expires
- Jan 8, 2028
PAR-25-203 due dates
3 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 05, 2025 | March 05, 2025 * | May 07, 2025 * | July 2025 | October 2025 | December 2025 |
| June 05, 2025 | July 05, 2025 * | September 07, 2025 * | November 2025 | January 2026 | April 2026 |
| October 05, 2025 | November 05, 2025 * | January 07, 2026 * | March 2026 | May 2026 | July 2026 |
| February 05, 2026 | March 05, 2026 * | May 07, 2026 * | July 2026 | October 2026 | December 2026 |
| June 05, 2026 | July 05, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 05, 2026 | November 05, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 05, 2027 | March 05, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
| June 05, 2027 | July 05, 2027 * | Not Applicable | November 2027 | January 2028 | April 2028 |
| October 05, 2027 | November 05, 2027 * | Not Applicable | March 2028 | May 2028 | July 2028 |
Projects funded under PAR-25-203
NIH RePORTER lists 37 projects funded under PAR-25-203 in FY2022–FY2026, with $51.3M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
37
Distinct projects, FY2022–FY2026
New awards
33
Type 1 (new project) award records
NIH funding
$51.3M
Award dollars under PAR-25-203, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 37 | 33 | $51.3M |
Institutions with the most funding
- University of Washington$7.3M · 4 projects
- University of Chicago$4.2M · 2 projects
- Stanford University$4.0M · 3 projects
- Battelle Pacific Northwest Laboratories$2.8M · 1 project
- University of California, San Diego$2.4M · 2 projects
- Seattle Children's Hospital$2.1M · 1 project
- Yale University$2.0M · 1 project
- Univ of Massachusetts Med Sch Worcester$2.0M · 1 project
Funding institutes
- NIGMS$51.3M · 37
Activity codes funded
- R0137 records
Most recent new awards
- Optical Probes for Polymerase Engineering (opens NIH RePORTER)
University of California-Irvine · 1R01GM165765-01 · NIGMS · Notice Sep 4, 2026
$1.2MR01
- Comprehensive characterization of CRISPR-Cas binding for optimal epigenome editing (opens NIH RePORTER)
Univ of Massachusetts Med Sch Worcester · 1R01GM165764-01 · NIGMS · Notice Sep 1, 2026
$2.0MR01
- Nanopore technology development for reading intact proteoforms (opens NIH RePORTER)
University of Washington · 1R01GM165889-01 · NIGMS · Notice Aug 25, 2026
$2.2MR01
- Precise genome editing in the zebrafish (opens NIH RePORTER)
Utah State Higher Education System--University of Utah · 1R01GM165452-01 · NIGMS · Notice Aug 25, 2026
$556KR01
- Imaging method for functional GPCR microanatomy with subcellular resolution and G protein specificity (opens NIH RePORTER)
University of California Los Angeles · 1R01GM165993-01 · NIGMS · Notice Aug 24, 2026
$1.2MR01
- Hybridization Chain Reaction: In Situ Amplification for Biological Imaging (opens NIH RePORTER)
California Institute of Technology · 1R01GM165318-01 · NIGMS · Notice Aug 13, 2026
$2.0MR01
What its predecessor PAR-22-127 funded
PAR-25-203 reissues PAR-22-127. Its funding history is the best guide to who wins under this program: 77 projects and $103.5M in FY2022–FY2026.
Projects funded
77
Distinct projects, FY2022–FY2026
New awards
68
Type 1 (new project) award records
NIH funding
$103.5M
Award dollars under PAR-22-127, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 27 | 23 | $12.7M |
| FY2024 | 48 | 21 | $19.2M |
| FY2025 | 73 | 21 | $43.2M |
| FY2026 | 65 | 3 | $28.4M |
Institutions with the most funding
- Yale University$4.1M · 3 projects
- University of California, San Francisco$4.0M · 2 projects
- Univ of North Carolina Chapel Hill$3.5M · 2 projects
- Boston University (Charles River Campus)$3.4M · 2 projects
- Massachusetts Institute of Technology$3.2M · 2 projects
- University of California-Irvine$3.2M · 2 projects
- University of Illinois at Urbana-Champaign$3.0M · 2 projects
- University of Wisconsin-Madison$3.0M · 3 projects
Funding institutes
- NIGMS$91.4M · 196
- NCI$6.9M · 11
- NIA$5.2M · 6
Activity codes funded
- R01212 records
- RF11 record
Most recent new awards
- Sequencing-free whole genome spatial transcriptomics at molecular resolution in aging tissue (opens NIH RePORTER)
Yale University · 1R01AG094838-01 · NIA · Notice Sep 29, 2026
$781KR01
- A multimodal measurement platform for unambiguous lipid identification (opens NIH RePORTER)
Battelle Pacific Northwest Laboratories · 1R01GM160387-01 · NIGMS · Notice Jul 29, 2026
$1.7MR01
- Technologies to probe the biophysical properties of aging cells (opens NIH RePORTER)
New York University School of Medicine · 1R01AG090618-01 · NIA · Notice Jan 23, 2026
$708KR01
- Label-free, single-molecule biosensing at ultrahigh speeds with metasurface-enhanced coherent Raman scattering (opens NIH RePORTER)
University of California-Irvine · 1R01GM160523-01 · NIGMS · Notice Sep 11, 2025
$1.3MR01
- Statistical and Deep Generative Modeling for Enhanced CyTOF Data Interpretation and Discovery (opens NIH RePORTER)
University of Texas Arlington · 1R01GM160515-01 · NIGMS · Notice Sep 10, 2025
$1.3MR01
- Development of an intelligent droplet acoustofluidic platform for automated liquid-liquid handing and monitoring in biomedical research (opens NIH RePORTER)
Trustees of Indiana University · 1R01GM160423-01 · NIGMS · Notice Sep 10, 2025
$371KR01
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-25-203. Contact the program officer at the institute that fits your research before applying.
- NIGMS · National Institute of General Medical Sciences
- none
Related notices
Jan 28, 2026 · NOT-OD-26-029
NIH Removing AIDS Application Due Dates from NOFOs. See Notice NOT-OD-26-029.
Mar 31, 2025 · NOT-OD-24-084
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25,…
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Notices of Special Interest (NOSIs)
NIH has attached 3 NOSIs to PAR-25-203; none are active now. A NOSI flags a topic an institute wants to fund through this NOFO.
Award terms
- Application types allowed
- NewRenewal The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are not limited but must reflect the actual needs of the proposed project. Applications proposing projects that have early feasibility data but significant risk due to their early stage of development may request reduced budgets or a reduced duration in their applications. Applications proposing projects that are well supported by feasibility studies and are ready to develop…
- Project period
- The scope of the proposed project should determine the project period. The maximum project period is 5 years, although investigators supported by NIGMS who are not ESIs will generally receive no more than four years of support in a project period. The grant may be renewed only one time. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications…
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the number of meritorious applications received.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-22-127.
- Companion NOFOs: PAR-25-202.
Other open NOFOs for R01
- PA-25-301NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)NIH · next due Feb 5, 2027
- PA-25-305NIH Research Project Grant (Parent R01 Clinical Trial Required)NIH · next due Feb 5, 2027
- PAR-25-077CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)NINDS · next due Oct 16, 2026
- PAR-25-371Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)NHGRI · next due Oct 20, 2026
- PAR-25-271NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)NCCIH · next due Oct 20, 2026
- PAR-25-267NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)NCCIH · next due Oct 20, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.